Bringing the fundamentals into focus…
Back to Janux Therapeutics, Inc.
How Janux Therapeutics, Inc. stacks up
JANX · against 470 other Healthcare companies of similar size
Valuation
8/ 100
Near the bottom of its peers.
Ranked #324 of 471 · scores higher than 10% of peers
Bars: peers in each 10-point band of the valuation score148 peers with a valuation score of 0–9, including JANX · Click a bar to see the companies
Why valuation scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its EBITDA yield and earnings yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -101.5% vs peer median 4.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -9.4% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -3.8% vs peer median 0.0%
Metric by metric
Position: dot = JANX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | JANX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 460 reported | -9.2% | 1.3% | 20% | 30% | |
| EBITDA yieldHigher is better · 476 reported | -101.5% | 4.2% | 1% | 50% | |
| Free cash flow yieldHigher is better · 204 reported | -3.8% | -2.3% | 43% | 20% | |
| Book yieldHigher is better · 466 reported | 85.3% | 41.2% | 84% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around JANX| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 324 | 1.1B USD | 8 | 32 | |
| 324 | 552M USD | 8 | 39 | |
| 324 | 1.1B USD | 8 | 26 | |
| 324 | 1.2B USD | 8 | 6 | |
| 324 | 1.1B USD | 8 | 50 | |
| 324 | 927M USD | 8 | 41 | |
| 324 | 820M USD | 8 | 41 | |
| 324 | 1.7B USD | 8 | 46 | |
| 324 | 879M USD | 8 | 36 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score